Healthcare :: Making the most of a visit to the doctor
For many patients, a visit to the primary care physician tends to be a one-sided conversation. Patients begin by stating one medical problem, and immediately the doctor takes over.
For many patients, a visit to the primary care physician tends to be a one-sided conversation. Patients begin by stating one medical problem, and immediately the doctor takes over.
According to a national study published this month in the American Journal of Health Education, moderate-intensity physical activity, such as slow walking, might not be helpful in losing weight.
Northwestern University researchers have discovered a drug that slows ? and may even halt ? the progression of Parkinson?s disease. The drug rejuvenates aging dopamine cells, whose death in the brain causes the symptoms of this devastating and widespread disease.
Men whose blood tests positive for the auto-antibody rheumatoid factor have a three times higher risk of heart disease, according to a study published online ahead of print in Heart.
Most Americans and others are not taking enough vitamin D, a fact that may put them at significant risk for developing cancer, according to a landmark study conducted by Creighton University School of Medicine.
Epidemiologists at the University of Liverpool and the Heart of Mersey have found that approximately half the recent fall in coronary heart disease deaths in the US is due to positive life style changes and a further half to medical therapies.
Strokes kill 45% more women than men in Canada, according to a new data analysis released by the Heart and Stroke Foundation. And that?s why Canadian women have a strong reason to be aware of the warning signs of stroke, says the Foundation.
Typified by high blood pressure, weight gain around the waist and problems regulating blood sugar, metabolic syndrome may also be associated with compromised heart structure and function, according to a paper published in the online open access journal BMC Cardiovascular Disorders.
On June 5, 2007, the New England Journal of Medicine published results of an interim analysis of the cardiovascular safety trial of rosiglitazone (brand name, Avandia).
Low levels of testosterone may increase the long-term risk of death in men over 50 years old, according to researchers with the Department of Family and Preventive Medicine at the University of California, San Diego School of Medicine.